Bonesupport
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Sweden · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Scheelevägen 19, Lund, Skane, 223 70, Sw...Phone Number
+46 462865370Website
www.bonesupport.comRevenue
$120.4 MillionStock Symbol
2B4.FIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Bonesupport
BoneSupport AB is a Swedish medical device company specializing in the development and commercialization of innovative orthobiologic solutions for bone healing and reconstruction. The company focuses on creating injectable synthetic bone graft substitutes that are designed to address complex bone injuries, defects, and infections in orthopedic and trauma surgery applications. BoneSupport's proprietary technology platform is based on calcium sulfate and hydroxyapatite formulations that provide both structural support and biological integration, promoting natural bone regeneration while gradually resorbing as new bone forms. The company's product portfolio is particularly recognized for its ability to combine bone void filling with local antibiotic delivery, offering surgeons a dual-action approach to treating bone infections such as osteomyelitis while simultaneously supporting bone healing. With a strong emphasis on clinical evidence and scientific research, BoneSupport works closely wRead more
Bonesupport Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bonesupport your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Bonesupport had a recent Job posting/layoffs
Product Launch: Get notified when Bonesupport launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Bonesupport recently announced quarterly report
Check out if Bonesupport is spiking on competitors!
Check if Bonesupport has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Bonesupport, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Bonesupport
Funding: Get notified immidiatlly once Bonesupport has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Bonesupport is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bonesupport is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bonesupport.
Bonesupport financials insights
Gather financial insights about Bonesupport, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Unspecified
$15M
2011
Unspecified
$120M
2012
Unspecified
$70M
2015
Private Equity
$14M
2016
Private Equity
$37M
Bonesupport Tech Stack
A closer look at the technologies used by Bonesupport
See more technologies
Most Recent Scoops
Project
Bonesupport has reported expanding its US market presence for CERAMENT G into revision arthroplasty, with market research indicating that approximately 60% of revision arthroplasty procedures currently receive some form of local antibiotics and that 80% of surveyed surgeons found CERAMENT G appealing to highly appealing for this indication.
Product Development, Medical Research
Earnings
Bonesupport has reported last-12-months growth for CERAMENT G in the US of 21% on a reported basis and 32% at constant exchange rates as of Q2, with the difference reflecting the impact of USD to SEK depreciation on reported figures throughout 2025 and H1 2026.
Earnings, Finance
Earnings
Bonesupport has reported selling and marketing expenses of SEK 135.3 million for Q2, compared with SEK 117.8 million in the prior year, with gross margin remaining stable at 93.8%, partially impacted by SEK 1.5 million in tariff effects compared to the same quarter last year.
Earnings, Spending/Investment, Accounting, Financial Reporting, Finance
Earnings
Bonesupport has reported US CERAMENT sales of SEK 295 million for Q2, compared with SEK 236 million in Q2 2025, reflecting continued strong traction in the US market.
Earnings, Finance
Earnings
Sales
Bonesupport News & Media
Bonesupport Holding AB (publ) (BOEUF) Q1 2026 Earnings Call Transcript
Bonesupport Holding AB (publ) (BOEUF) Q1 2026 Earnings Call April 22, 2026 4:00 AM EDTCompany ParticipantsTorbjorn Skold - Chief Executive OfficerHåkan...Bonesupport Holding AB (publ) (BOEUF) Q4 2025 Earnings Call Transcript
Bonesupport Holding AB (publ) (BOEUF) Q4 2025 Earnings Call February 24, 2026 4:00 AM ESTCompany ParticipantsTorbjorn Skold - Chief Executive OfficerHåkan...BONESUPPORT has completed the issuance of series C shares - MarketScreener
The Board of Directors of BONESUPPORT HOLDING AB has, as previously communicated, on 5 March 2024 resolved issue redeemable and convertible series C shares and to, conditional upon subscription and...BONESUPPORT’s FDA Authorized CERAMENT® G to be featured at Orthopedic Trauma Association Annual Meeting (OTA)
Orthobiologics Leader Presents Long-Term Insights from New Groundbreaking Oxford University Patient Study (PRWeb October 11, 2022) Read the full story at https://www.prweb.com/releases/bonesupports_fda_authorized_cerament_g_to_be_featured_at_orthopedic_trauma_association_annual_meeting_ota/prweb18949980.htm
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Bonesupport
Sign Up For FreeTo access detailed company insights
BoneSupport AB is a Swedish medical device company specializing in the development and commercialization of innovative orthobiologic solutions for bone healing and reconstruction. The company focuses on creating injectable synthetic bone graft substitutes that are designed to address complex bone injuries, defects, and infections in orthopedic and... Read More
